Article Information
History
- April 28, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Abay Sisay1,2,¶,*,
- Sonja Hartnack3,¶,
- Abebaw Tiruneh1,4,
- Yasin Desalegn4,
- Abraham Tesfaye1,5 and
- Adey Feleke Desta2
- 1Department of Medical Laboratory Sciences, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
- 2Department of Microbial, Cellular and Molecular Biology, College of Natural and Computational Sciences, Addis Ababa University, Addis Ababa, Ethiopia
- 3Section of Epidemiology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland
- 4Addis Ababa Public Health Research and Emergency Management Laboratory, Addis Ababa Health Bureau, Addis Ababa, Ethiopia
- 5Diagnostic Unit, Center for Innovative Drug Development and Therapeutic Trials for Africa, CDT-Africa, Addis Ababa, Ethiopia
- ↵*Corresponding author abusis27{at}gmail.com
↵¶ These authors contributed equally to this work
Posted April 28, 2022.
Evaluating diagnostic accuracies of Panbio™ COVID-19 rapid antigen test and RT-PCR for the detection of SARS-CoV-2 in Addis Ababa, Ethiopia using Bayesian Latent-Class Models (BLCM)
